Cargando…

Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats

BACKGROUND/OBJECTIVE: Orostachys japonicus A. Berger (Crassulaceae) has been used in traditional herbal medicines in Korea and other Asian countries to treat various diseases, including liver disorders. In the present study, the anti-fibrotic effects of O. japonicus extract (OJE) in cellular and exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Koppula, Sushruta, Yum, Mun-Jeong, Kim, Jin-Seoub, Shin, Gwang-Mo, Chae, Yun-Jin, Yoon, Tony, Chun, Chi-Su, Lee, Jae-Dong, Song, MinDong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Nutrition Society and the Korean Society of Community Nutrition 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712497/
https://www.ncbi.nlm.nih.gov/pubmed/29209457
http://dx.doi.org/10.4162/nrp.2017.11.6.470
_version_ 1783283227403747328
author Koppula, Sushruta
Yum, Mun-Jeong
Kim, Jin-Seoub
Shin, Gwang-Mo
Chae, Yun-Jin
Yoon, Tony
Chun, Chi-Su
Lee, Jae-Dong
Song, MinDong
author_facet Koppula, Sushruta
Yum, Mun-Jeong
Kim, Jin-Seoub
Shin, Gwang-Mo
Chae, Yun-Jin
Yoon, Tony
Chun, Chi-Su
Lee, Jae-Dong
Song, MinDong
author_sort Koppula, Sushruta
collection PubMed
description BACKGROUND/OBJECTIVE: Orostachys japonicus A. Berger (Crassulaceae) has been used in traditional herbal medicines in Korea and other Asian countries to treat various diseases, including liver disorders. In the present study, the anti-fibrotic effects of O. japonicus extract (OJE) in cellular and experimental hepatofibrotic rat models were investigated. MATERIALS/METHODS: An in vitro hepatic stellate cells (HSCs) system was used to estimate cell viability, cell cycle and apoptosis by MTT assay, flow cytometry, and Annexin V-FITC/PI staining techniques, respectively. In addition, thioacetamide (TAA)-induced liver fibrosis was established in Sprague Dawley rats. Briefly, animals were divided into five groups (n = 8): Control, TAA, OJE 10 (TAA with OJE 10 mg/kg), OJE 100 (TAA with OJE 100 mg/kg) and silymarin (TAA with Silymarin 50 mg/kg). Fibrosis was induced by treatment with TAA (200 mg/kg, i.p.) twice per week for 13 weeks, while OJE and silymarin were administered orally two times per week from week 7 to 13. The fibrotic related gene expression serum biomarkers glutathione and hydroxyproline were estimated by RT-PCR and spectrophotometry, respectively, using commercial kits. RESULTS: OJE (0.5 and 0.1 mg/mL) and silymarin (0.05 mg/mL) treatment significantly (P < 0.01 and P < 0.001) induced apoptosis (16.95% and 27.48% for OJE and 25.87% for silymarin, respectively) in HSC-T6 cells when compared with the control group (9.09%). Further, rat primary HSCs showed changes in morphology in response to OJE 0.1 mg/mL treatment. In in vivo studies, OJE (10 and 100 mg/kg) treatment significantly ameliorated TAA-induced alterations in levels of serum biomarkers, fibrotic related gene expression, glutathione, and hydroxyproline (P < 0.05-P < 0.001) and rescued the histopathological changes. CONCLUSIONS: OJE can be developed as a potential agent for the treatment of hepatofibrosis.
format Online
Article
Text
id pubmed-5712497
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Nutrition Society and the Korean Society of Community Nutrition
record_format MEDLINE/PubMed
spelling pubmed-57124972017-12-05 Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats Koppula, Sushruta Yum, Mun-Jeong Kim, Jin-Seoub Shin, Gwang-Mo Chae, Yun-Jin Yoon, Tony Chun, Chi-Su Lee, Jae-Dong Song, MinDong Nutr Res Pract Original Research BACKGROUND/OBJECTIVE: Orostachys japonicus A. Berger (Crassulaceae) has been used in traditional herbal medicines in Korea and other Asian countries to treat various diseases, including liver disorders. In the present study, the anti-fibrotic effects of O. japonicus extract (OJE) in cellular and experimental hepatofibrotic rat models were investigated. MATERIALS/METHODS: An in vitro hepatic stellate cells (HSCs) system was used to estimate cell viability, cell cycle and apoptosis by MTT assay, flow cytometry, and Annexin V-FITC/PI staining techniques, respectively. In addition, thioacetamide (TAA)-induced liver fibrosis was established in Sprague Dawley rats. Briefly, animals were divided into five groups (n = 8): Control, TAA, OJE 10 (TAA with OJE 10 mg/kg), OJE 100 (TAA with OJE 100 mg/kg) and silymarin (TAA with Silymarin 50 mg/kg). Fibrosis was induced by treatment with TAA (200 mg/kg, i.p.) twice per week for 13 weeks, while OJE and silymarin were administered orally two times per week from week 7 to 13. The fibrotic related gene expression serum biomarkers glutathione and hydroxyproline were estimated by RT-PCR and spectrophotometry, respectively, using commercial kits. RESULTS: OJE (0.5 and 0.1 mg/mL) and silymarin (0.05 mg/mL) treatment significantly (P < 0.01 and P < 0.001) induced apoptosis (16.95% and 27.48% for OJE and 25.87% for silymarin, respectively) in HSC-T6 cells when compared with the control group (9.09%). Further, rat primary HSCs showed changes in morphology in response to OJE 0.1 mg/mL treatment. In in vivo studies, OJE (10 and 100 mg/kg) treatment significantly ameliorated TAA-induced alterations in levels of serum biomarkers, fibrotic related gene expression, glutathione, and hydroxyproline (P < 0.05-P < 0.001) and rescued the histopathological changes. CONCLUSIONS: OJE can be developed as a potential agent for the treatment of hepatofibrosis. The Korean Nutrition Society and the Korean Society of Community Nutrition 2017-12 2017-11-02 /pmc/articles/PMC5712497/ /pubmed/29209457 http://dx.doi.org/10.4162/nrp.2017.11.6.470 Text en ©2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Koppula, Sushruta
Yum, Mun-Jeong
Kim, Jin-Seoub
Shin, Gwang-Mo
Chae, Yun-Jin
Yoon, Tony
Chun, Chi-Su
Lee, Jae-Dong
Song, MinDong
Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
title Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
title_full Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
title_fullStr Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
title_full_unstemmed Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
title_short Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
title_sort anti-fibrotic effects of orostachys japonicus a. berger (crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712497/
https://www.ncbi.nlm.nih.gov/pubmed/29209457
http://dx.doi.org/10.4162/nrp.2017.11.6.470
work_keys_str_mv AT koppulasushruta antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT yummunjeong antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT kimjinseoub antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT shingwangmo antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT chaeyunjin antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT yoontony antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT chunchisu antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT leejaedong antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats
AT songmindong antifibroticeffectsoforostachysjaponicusabergercrassulaceaeonhepaticstellatecellsandthioacetamideinducedfibrosisinrats